Cargando…
S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
Pancreatic cancer remains a disease that is very difficult to treat. S100 proteins are small calcium binding proteins with diverse intra- and extracellular functions that modulate different aspects of tumorigenesis, including tumor growth and metastasis. High mobility group box 1 (HMGB1) protein is...
Autores principales: | Mandarino, Angelo, Thiyagarajan, Swetha, Martins, Allana C. F., Gomes, Roberto da Silva, Vetter, Stefan W., Leclerc, Estelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452588/ https://www.ncbi.nlm.nih.gov/pubmed/37627239 http://dx.doi.org/10.3390/biom13081175 |
Ejemplares similares
-
RAGE Up-Regulation Differently Affects Cell Proliferation and Migration in Pancreatic Cancer Cells
por: Swami, Priyanka, et al.
Publicado: (2020) -
The S100B/RAGE Axis in Alzheimer's Disease
por: Leclerc, Estelle, et al.
Publicado: (2010) -
Inhibition of the Receptor for Advanced Glycation End Products Enhances the Cytotoxic Effect of Gemcitabine in Murine Pancreatic Tumors
por: Swami, Priyanka, et al.
Publicado: (2021) -
RAGE Signaling in Melanoma Tumors
por: Olaoba, Olamide T., et al.
Publicado: (2020) -
Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
por: Taneja, Sakshi, et al.
Publicado: (2021)